Clinical Trials Directory

Trials / Completed

CompletedNCT04204876

Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Longitudinal imaging in patients with large vessel vasculitis to predict further disease course

Detailed description

This explorative longitudinal prospective observational study is to explore different aspects of vessel wall characteristics as detected by magnet resonance imaging (MRI) techniques and positron emission tomography/computer tomography (PET/CT) in patients with large vessel giant cell Arteriitis (LV-GCA) for their usefulness as predictive factor for future giant cell arteritis (GCA) relapse. It analyses parameters in PET/CT and MRI in patients with GCA at treatment stop which correlate with GCA relapse within the first 6 months after treatment stop. Patients included in the established local GCA database (BARK) will be screened for eligibility. Aortal imaging is performed during routine care according to established guidelines at diagnosis and during Follow Up at least every two years and before treatment stop.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnet Resonance Imaging (MRI)MRI with and without Gadolinium contrast agent for the following vessels: thoracic aorta (ascending, arch, descending arch, left and right common carotic, subclavian, and vertebral artery)
DIAGNOSTIC_TESTPET/CT analysisStandard value uptake measurement (SUV) based on quantitative score normalized to liver (SUV vessel max/liver mean) at the following vessel regions: Carotid artery: common, internal, external; Subclavian artery; Axillary artery; Vertebral artery; Thoracic Aorta; Abdominal Aorta; Common femoral artery; Deep femoral artery; Popliteal artery

Timeline

Start date
2020-05-28
Primary completion
2023-08-05
Completion
2023-08-05
First posted
2019-12-19
Last updated
2024-01-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04204876. Inclusion in this directory is not an endorsement.